Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New AI insulin system aims to ease diabetes management

NCT ID NCT07039617

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times

Summary

This study tests a smart insulin delivery algorithm called AIDANET in adults with type 1 diabetes. It compares three modes: fully automatic, hybrid (with some user input), and a mix. The goal is to see which mode keeps blood sugar in a healthy range more consistently. Participants will use their own devices plus a study-provided pump and continuous glucose monitor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Virginia Center for Diabetes Technology

    RECRUITING

    Charlottesville, Virginia, 22903, United States

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.